ViiV Healthcare’s Cabenuva beats daily oral ART in Phase IIIb trial
ViiV Healthcare’s long-acting HIV treatment Cabenuva showed superior rates of viral suppression compared with oral antiretroviral therapy (ART) in adults…
News
Eye implant triggers sight improvements in GA at 36-months, pivotal study finds
AbbVie, Genmab report positive results from Phase III EPCORE DLBCL-2 trial
First patient dosed in Vial’s Phase Ib trial of IL-13 x TSLP antibody
Vaxcyte’s stock up after pneumococcal vaccine proves non-inferiority
Clinical trial experts turn to AI and new partnerships to tackle growing trial complexity
EADV26: Key late-stage readouts from the conference
Surrozen secures FDA clearance for SZN-8141 clinical trial
